Use of donor lymphocyte infusions (DLI) for the treatment of relapse after allogeneic bone marrow transplantation (ABMT): Effective GVT in chronic myeloid leukemia (CML) with no clinical GVHD.

被引:0
|
作者
Hahn, TE [1 ]
Alam, AR [1 ]
Miller, A [1 ]
Meteer, J [1 ]
Dascomb, S [1 ]
Baer, MR [1 ]
Bambach, B [1 ]
Bernstein, S [1 ]
Bernstein, Z [1 ]
Chanan-Khan, A [1 ]
Czuczman, M [1 ]
Slack, J [1 ]
Wetzler, M [1 ]
Becker, J [1 ]
Stewart, C [1 ]
McCarthy, PL [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5239
引用
收藏
页码:366B / 366B
页数:1
相关论文
共 50 条
  • [21] Donor lymphocyte infusion for treatment of hematological leukemia relapse in children after allogeneic bone marrow transplantation.
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Ladoñ, D
    Witt, M
    BONE MARROW TRANSPLANTATION, 2002, 30 : S63 - S63
  • [22] Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions
    S Tauro
    P Mahendra
    Bone Marrow Transplantation, 2001, 27 : 757 - 759
  • [23] Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions
    Tauro, S
    Mahendra, P
    BONE MARROW TRANSPLANTATION, 2001, 27 (07) : 757 - 759
  • [24] Late response to Donor Lymphocyte Infusions (DLI) in patients with Chronic Myeloid Leukaemia (CML) relapsing after Allogeneic Stem Cell Transplantation (Allo-SCT)
    Gómez, M
    Urbano-Ispizua, A
    Fernández-Avilés, F
    Rovira, M
    Perales, M
    Martínez, C
    Cervantes, F
    Carreras, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S124 - S124
  • [25] Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Dazzi, F
    Szydlo, RM
    Cross, NCP
    Craddock, C
    Kaeda, J
    Kanfer, E
    Cwynarski, K
    Olavarria, E
    Yong, A
    Apperley, JF
    Goldman, JM
    BLOOD, 2000, 96 (08) : 2712 - 2716
  • [26] Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia
    Gilleece, MH
    Dazzi, F
    LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 23 - 28
  • [27] Treatment of chronic myeloid leukemia relapses after allogeneic bone marrow transplantation
    Klamová, H
    Lukásová, M
    Vitek, A
    Sajdová, J
    Hrabánek, J
    Moravcová, J
    Haskovec, C
    Brziková, J
    Michalová, K
    Zemanová, Z
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 317 - 317
  • [28] Effects of donor lymphocyte infusions (DLI) on prevention of disease relapse after 0T-cell depleted (TCD) allogeneic bone marrow transplantation (BMT).
    Soiffer, RJ
    Alyea, EP
    Canning, CM
    Weller, E
    Webb, I
    Schlossman, RL
    Anderson, KC
    Ritz, J
    BLOOD, 2000, 96 (11) : 196A - 196A
  • [29] G-CSF given to donors before apheresis does not prevent aplasia in patients treated with donor lymphocyte infusions (DLI) for recurrent chronic myeloid leukemia (CML) after bone marrow transplantation (BMT).
    Flowers, MED
    Leisenring, W
    Beach, K
    Riddell, S
    Radich, JP
    Higano, CS
    Rowley, SD
    Chauncey, TR
    Bensinger, WI
    Sanders, JE
    Anasetti, C
    Storb, R
    Wade, J
    Appelbaum, FR
    Martin, PJ
    BLOOD, 1999, 94 (10) : 669A - 669A
  • [30] CHRONIC MYELOID-LEUKEMIA - MANAGEMENT OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KUMAR, L
    LEUKEMIA & LYMPHOMA, 1993, 10 (03) : 165 - 171